Trials / Completed
CompletedNCT03541200
Long-term Safety and Efficacy Study of MT-8554 in Postmenopausal Women With Vasomotor Symptoms
An Open-label, Long Term Extension Study of MT-8554 in Postmenopausal Women Experiencing Moderate to Severe Vasomotor Symptoms Who Completed Study MT-8554-A01
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 190 (actual)
- Sponsor
- Tanabe Pharma America, Inc. · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
An open-label, long term extension study of MT-8554 in postmenopausal women experiencing moderate to severe vasomotor symptoms who completed Study MT-8554-A01
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MT-8554 | MT-8554 Oral |
Timeline
- Start date
- 2018-04-18
- Primary completion
- 2019-11-15
- Completion
- 2019-11-15
- First posted
- 2018-05-30
- Last updated
- 2026-01-23
- Results posted
- 2022-10-03
Locations
53 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03541200. Inclusion in this directory is not an endorsement.